Home/Filings/4/0001367982-07-000269
4//SEC Filing

AMYLIN PHARMACEUTICALS INC 4

Accession 0001367982-07-000269

CIK 0000881464operating

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 6:09 PM ET

Size

8.6 KB

Accession

0001367982-07-000269

Insider Transaction Report

Form 4
Period: 2007-06-01
Transactions
  • Exercise/Conversion

    Common Stock

    2007-06-01$18.85/sh+2,000$37,70025,747 total
  • Sale

    Common Stock

    2007-06-01$46.00/sh2,000$91,99923,747 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2007-06-012,0007,800 total
    Exercise: $18.85Exp: 2013-05-12Common Stock (2,000 underlying)
Footnotes (2)
  • [F1]This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]5,825 options vested on 05/12/04, and monthly after that, until all the 23,300 options were completely vested on 05/12/07.

Issuer

AMYLIN PHARMACEUTICALS INC

CIK 0000881464

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000881464

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 6:09 PM ET
Size
8.6 KB